Invitrogen™ Kit ELISA iNOS humain

Réf. : BL-RE-090713Réf. fabricant : EEL035 96 Tests
694,00 € HT

iNOS (Inducible Nitric oxide, NO, NOS) is an inorganic, gaseous free radical that carries a variety of messages between cells. Vasorelaxation, neurotransmission and cytotoxicity can all be potentiated through cellular response to NO. NO production…

Numéro d’adhésion
P35228
Plage de dosage
78.13 to 5000 pg/mL
Sensibilité du dosage
46.88 pg/mL
Conjugué
HRP
Type de produit
ELISA
Marque
Invitrogen

iNOS (Inducible Nitric oxide, NO, NOS) is an inorganic, gaseous free radical that carries a variety of messages between cells. Vasorelaxation, neurotransmission and cytotoxicity can all be potentiated through cellular response to NO. NO production…

iNOS (Inducible Nitric oxide, NO, NOS) is an inorganic, gaseous free radical that carries a variety of messages between cells. Vasorelaxation, neurotransmission and cytotoxicity can all be potentiated through cellular response to NO. NO production is mediated by members of the nitric oxide synthase (NOS) family. iNOS is expressed in liver and inducible by a combination of lipopolysaccharide and certain cytokines. NOS catalyzes the oxidization of L-arginine to produce L-citrulline and NO. Two constitutive isoforms, brain or neuronal NOS (b or nNOS, type I) and endothelial cell NOS (eNOS, type III), and one inducible isoform (iNOS, type II), have been cloned. All NOS isoforms contain calmodulin, nicotinamide adenine dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) binding domains. iNOS is found in a variety of cell types including macrophages, hepatocytes, synoviocytes, and smooth muscle cells. Cytokines such as interferon-gamma (IFN), tumor necrosis factor (TNF), interleukin-1 and -2, and lipopolysaccarides (LPS) cause an increase in iNOS mRNA, protein, and activity levels. Protein kinase C-stimulating agents exhibit the same effect on iNOS activity. After cytokine induction, iNOS exhibits a delayed activity response which is then followed by a significant increase in NO production over a long period of time. Three related iNOS pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. Diseases associated with iNOS dysfunction include achalasia and impotence.

Sensibilité

Sensibilité du dosage : 46,88 pg/mL.

Plage de mesure

Plage de dosage : 78,13 à 5000 pg/mL.

Durée du dosage

Durée totale du dosage : 3 h 30 min.

Échantillons

Type d’échantillon : Plasma (volume 100 µL).

Conjugué

Conjugué : HRP.

Caractéristiques techniques

Général
MarqueInvitrogen
Réf. fournisseur (Fisher Scientific)18087364
Caractéristiques
Numéro d’adhésionP35228
Plage de dosage78.13 to 5000 pg/mL
Sensibilité du dosage46.88 pg/mL
ConjuguéHRP
Type de produitELISA
Type d’échantillonPlasma
À utiliser avec (équipement)Colorimetric Microplate Reader
Identification génétique (Entrez)4843
Symbole de gène(s)Nos2
Coefficient de variation inter-dosage<10%
Coefficient de variation intra-dosage<10%
Contenus des kitsPre-coated 96 well plate, Standard, Biotinylated Detection Antibody, HRP Conjugate, Standard & Sample Diluent, Biotinylated Detection Antibody Diluent, HRP Conjugate Diluent, Wash Buffer, TMB Substrate, Stop Solution, Plate Sealer
Marqueur ou colorantHRP
Quantité96 Tests
État réglementaireRUO
CibleHuman
Heure du test1 hr 20 min
Caractéristiques physiques
Volume d’échantillon100 µL
Stockage et expédition
Conditions de stockageRefer to product documentation for component specific storage temperature.
Durée totale du dosage3 hr 30 min

Origine et douane

Réf. fabricantEEL035
Pays d’origineChine
Code douanier (SH)3822 11 00 00
Une question, une configuration particulière ?
Contactez-nous pour un devis.